I wonder if they are gearing up for a new trial with an updated device? Or are they just advertising what they have and what it has been used for already.
Here is a link to the clinical trial.
https://clinicaltrials.gov/ct2/show/results/N...amp;rank=1
Use of Pulsed Electromagnetic Fields (PEMF) After Breast Reconstruction Surgery
Good to see they are at least using Twitter to market themselves.
Looks like they are starting to market the Sofpulse (Twitter update).
The next PR "update" will hopefully be heart news.
Then after that will be FDA registration completion to start clinical trials of Theracap.
Around the same time of this should be clinical trial of tPEMF to treat ischemic stroke.
Then we should be be due for some pre-clinical results of the other organs and conditions being treated with Immunotronics.